WWARN provides the malaria community with a reliable data collection platform to facilitate data sharing, pooled data analyses, and application of these findings to provide evidence for policy makers and drug developers to optimise the use of antimalarials. WWARN also develops free to use tools and training to support researchers in malaria endemic countries.
Deepen your understanding of the health challenges in resource limited contexts, and learn about exciting developments in research to inform viable and sustainable solutions, 3rd to 7th Sept 2018.
The MSc in International Health and Tropical Medicine provides a multidisciplinary and interdisciplinary foundation in global health. This course embraces the breadth and complexity of global health challenges facing resource limited contexts and equips candidates with the tools and awareness to contribute to innovative solutions.
Did you know that as part of Oxford University's Campaign, you can donate directly to Tropical Medicines unit on the Thai-Myanmar border?
Investments worth more than £2.7bn are being pledged today in a drive to halve the number of malaria cases across the Commonwealth. Heads of state and business leaders are convening in London to galvanise the fight against the disease, which has seen a resurgence in some areas.
As the second largest international donor, the UK has been at the forefront of efforts to reduce the number of cases for many years by investing in treatment, prevention and research, including the fight against the threat of drug resistance. The UK has announced further support for the fight against malaria to save more than 120,000 lives ahead of a Malaria Summit tomorrow with Commonwealth leaders.
Pailin, a small settlement nestling in tropical rainforest near Cambodia’s border with Thailand, lies at the heart of a region that has seen successive waves of resistance to malaria drugs arise in local people and then spread across the globe. As new waves of the disease threaten our health, worried scientists want to conduct a mass inoculation in a Cambodian region where new vaccines always seem to stop being effective.
10 April 2018 (Bangkok) – Giving paracetamol (acetaminophen) to patients ill with severe malaria made them less likely to develop potentially fatal kidney failure, say researchers in a recent study in Clinical Infectious Diseases.
More effective diagnosis and treatments are needed to reduce the morbidity and mortality affecting malaria patients. Researchers at the Malaria Laboratory at MORU study the pathophysiology of the disease, and test new compound drugs for anti-malarial activity. In the context of growing artemisinin resistance, this research will have a global impact.
This new Lancet malaria seminar is one of a series of clinically focused, structured, up-to-date reviews which are grouped together in The Lancet Clinic with other relevant content. The aim of the seminars is to give a comprehensive overview of diseases to practising clinicians, emphasising recent advances, controversies and uncertainties.
Antimicrobial resistance (AMR) is a serious threat to public health. A new report describes the role of supranational networks in AMR surveillance in low- and middle-income countries (LMICs); Liz Ashley and colleagues analysed networks that were in existence between January 2000 and August 2017. This study reveals the challenges of establishing sustainable and effective networks to tackle resistance to antimicrobial medicines.